HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
This study developed a new vaginal hydrogel to treat genitourinary syndrome of menopause, aiming to improve drug retention and patient
HPBCD-enhanced Vaginal Hydrogel: Innovative Treatment for Menopause Symptoms
This study developed a new vaginal hydrogel to treat genitourinary syndrome of menopause, aiming to improve drug retention and patient
Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
Purpose: Although sugammadex may promote earlier postoperative mobilization and transiently affect coagulation parameters, its association with the risk of venous
Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
The Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition” will be published in the International Journal of Molecular Sciences
Cyclodextrins hit the golf course seven years ago — and they are still there
Golf balls may look simple, but they are highly engineered products. Their performance depends on carefully designed combinations of cores,
Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
Researchers from Türkiye developed GE11-functionalized curcumin/carboxymethyl-β-cyclodextrin (Cur/CM-βCD) supramolecular assemblies, using GE11 as an EGFR-targeting peptide, to enhance the therapeutic potential
REVTORPYKâ„¢: A New FDA Approval for Gedatolisib/HPBCD composition
A new chapter in targeted cancer therapy On July 14, 2026, the U.S. FDA approved REVTORPYKâ„¢ (gedatolisib), developed by Celcuity,
Reducing Cholesterol with β-CDP: Insights for NPC and AD
Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are neurodegenerative disorders characterised by cognitive dysfunction and neurological impairment. In
9th China International Biotechnology Conference & Exhibition (BIOTEC-CHINA 2027)
BIOTEC-CHINA 2027 will be held from 23-25 April 2027 in Beijing Huanghe Jingdu Conference Center, Beijing China. BIOTEC-CHINA 2027 call
Fast-Dissolving HPβCD Nanofibers with a combination of 3 drugs: A New Solution for Pain Relief
Researchers from the United States 🇺🇸 developed fast-dissolving HPβCD nanofibers containing a three-drug combination of aspirin, paracetamol, and caffeine commonly
Cyclodextrin Helps Analyzing 3D Histology of Archived Human Tissues
What if decades-old human tissue archives could be transformed from thin, two-dimensional histological sections into detailed three-dimensional maps of cells,